VPIM
DTIL icon

Vanguard Personalized Indexing Management’s Precision BioSciences DTIL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,127
Closed -$72.5K – 2002
2025
Q3 		$72.5K Buy
+13,127
New +$62.9K ﹤0.01% 1862

Other funds holding DTIL

EAM
Empery Asset Management New York $83M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Personalized Indexing Management's DTIL Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Precision BioSciences (DTIL) in Q4 2025, closing a stake of 13,127 shares — an estimated $72.5K sold.

Vanguard Personalized Indexing Management first reported a position in DTIL in Q3 2025 and held it in 1 quarter. The position peaked at $72.5K in Q3 2025. 69 funds tracked by Wall St. Rank hold DTIL as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Precision BioSciences position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 13,127 Precision BioSciences shares in Q4 2025, an estimated $72.5K.
  • Vanguard Personalized Indexing Management first reported a position in Precision BioSciences in Q3 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Precision BioSciences position peaked at $72.5K in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.